Viewing Study NCT01285505


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2025-12-26 @ 1:50 AM
Study NCT ID: NCT01285505
Status: WITHDRAWN
Last Update Posted: 2021-01-28
First Post: 2011-01-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module